Life Sciences Tools and Services
Company Overview of EMD Millipore Corporation
EMD Millipore Corporation provides solutions and services for research, development, and production of biotechnology and pharmaceutical drug therapies. It offers bioscience products and services, such as antibodies and assays, protein detection and quantification, inhibitors and biochemicals, proteins and enzymes, cell culture and systems, genomic analysis, and cell analysis; lab solutions, such as chemical and reagents, IVD/OEM materials and reagents, microbiological testing and process monitoring, and related services; and process solutions, including sterile filtration, virus reduction, biopharma raw materials, drug delivery compounds, engineering, and validation services. The company als...
290 Concord Road
Billerica, MA 01821-7037
Founded in 1954
Key Executives for EMD Millipore Corporation
Chief Executive Officer and President
Head of Finance and Controlling
Head of Global Operations and Member of Management Board
Member of Management Board and President of Emd Millipore Division
Member of Management Board and Head of Emd Millipore's Bioscience Business Unit
Compensation as of Fiscal Year 2015.
EMD Millipore Corporation Key Developments
EMD Millipore Adds Protein Pegylation to Portfolio of Services for Biopharmaceutical Industry through Collaboration with celares GmbH
Jul 27 15
EMD Millipore announced a collaboration with celares GmbH to provide pegylation services to customers developing protein-based therapeutics and biosimilars. The new service offering enabled by the collaboration includes feasibility studies, process and analytical development, and scale-up from milligram to gram quantities required for pilot and subsequent commercial scale. Pegylation, the attachment of polyethylene glycol to a molecule, can significantly improve the pharmacological and physicochemical properties of peptide and protein therapeutics and reduce side effects. This well-recognized delivery system for biologics can enhance protein stability, bioavailability and solubility, overcoming common challenges in the development of these therapeutics. The new services will leverage EMD Millipore's broad range of functionalized PEG products of different molecular weight and activation chemistry, as well as buffers, solvents and excipients, unit operations employed during the pegylation process and subsequent purification including tangential and normal flow filtration and chromatography.
EMD Millipore Announces Three Additions to its MAS-100® Product Family
Jun 16 15
EMD Millipore announced three additions to its MAS-100® product family. The MAS-100 Iso MH® and MAS-100 Iso NT® systems were developed for use in isolators and enable sampling at critical control points. The distinguishing feature of the MAS-100 Iso MH® system is its four sampling heads, which allow for increased monitoring capacity compared to single-head systems. The compact and easy-to-handle design of the MAS-100 VF® air sampler makes it well-suited for use in controlled environments. The MAS-100 Iso NT® system for monitoring air in isolators was developed according to GAMP 4 and ISO® 14698 standards. The fully validated air sampler contains an innovative double valve which integrates the sampling head into the decontamination process of the isolator. For added safety, electronic and moving parts remain outside the critical zone and an internal pump with flow control enables automatic disinfection of the sampling head and the aspiration tube. The MAS-100 Iso MH® air sampler offers all the benefits of the MAS-100 Iso NT® and allows installation of up to four sampling heads at all critical control points. Multiple heads from one pump provide increased capacity, easier installation and lower cost than four equivalent single-head systems. Additionally, the system extends up to 10 meters in tube length, which facilitates use in larger isolators. The system was developed according to GAMP 5 and ISO® 14698 standards. The MAS-100 VF® active air sampler was validated and developed for air monitoring in controlled environments. The system's compact design allows for ease of operation, and its added handle can be mounted on a tripod to test different angles for fixed applications. Electronic speed control ensures a consistent and accurate flow rate, and a touch-slide control menu enables simple menu navigation. The system programs sample volumes from 1 to 1,000 liters with five presets to assure reproducible results. The MAS-100® family includes systems for testing air and compressed gases in cleanrooms, aseptic production areas, isolators, and other controlled environments. MAS-100® microbial air samplers comply with the guidelines as specified in the new ISO® 14698 part 1 and part 2 standards.
EMD Millipore Expands Provantage Biodevelopment Services with Addition of Provantage Clone Generation Service
Jun 15 15
EMD Millipore announced expansion of its Provantage Biodevelopment Services to include a Clone Generation Service. With this addition, the company now provides a full range of services for optimizing yield, productivity, consistency and efficiency of clinical scale drug products. The new Clone Generation Service includes expression of recombinant proteins such as hormones, growth factors and mono- and bi-specific monoclonal antibodies. Customers can choose from DG44 and CHO-S cell lines, both of which are widely used for reliable and high-yield production of biologics. Availability of two cell lines offers greater flexibility to meet both the technical requirements and business objectives of customers. While the DG44 cell line offers freedom for process development, the CHO-S line can be more cost effective. Every clone generation is fully documented to ensure traceability from the source and demonstrate that the cell is clonal, making the cells usable for clinical production, IND submission and acceptance. Clone generation includes DNA synthesis of the sequence encoding the biologic, cloning of the sequence in a vector, transfection, and preparation of stable pools of producing cells, amplification of the expression cassette and subcloning of high-producing cells. The final deliverable is a pre-master cell bank of high-producing clones and a cell line generation report.
Similar Private Companies By Industry
Recent Private Companies Transactions